Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
Competitive Landscape of the DNA Testing Service Market
In the DNA Testing Service Market 's competitive landscape, numerous key competitors are driving innovation and growth. The company's overview, financials, revenue, market potential, R&D investment, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance are all included in the details. Market rivalry is encouraging technological and design innovations to create DNA Testing Service that fulfill both consumer wants and sustainability goals, keeping the market dynamic and competitive.
In November 2023, Renowned Chinese bioanalytical CRO Denali Medpharma was successfully bought by Resolian. Resolian's bioanalysis laboratory activities have been expanded to include facilities in the United States, the United Kingdom, Australia, and China through this acquisition. (Source: https://www.businesswire.com/news/home/20231101490232/en/Resolian-Acquires-China-Based-Bioanalytical-CRO-Denali-Medpharma) In Novemeber 2020, The FDA has extended the approval of the "liquid biopsy" cancer blood test, which can help match patients to possible treatments by identifying genetic alterations in tumor DNA found in the blood. (Source: https://www.cancer.gov/news-events/cancer-currents-blog/2020/fda-foundation-one-cancer-liquid-biopsy-expanded-approval#:~:text=The%20Food%20and%20Drug%20Administration,been%20released%20into%20the%20blood.) In January 2020, The Finnish genetic testing business Blueprint Genetics was acquired by Quest Diagnostics, which has increased their capacity for next-generation sequencing of uncommon disorders. (Source: https://newsroom.questdiagnostics.com/2020-01-22-Quest-Diagnostics-Acquires-Blueprint-Genetics-to-Broaden-Access-to-Actionable-Insights-for-Genetic-and-Rare-Diseases)
Click any bar or cell to request the full company profile
Company
2022 (A)
2023 (A)
2024 (A)
2025 (A)
Charles River Laboratories (U.S.)
•••
•••
•••
•••
Medpace (U.S.)
•••
•••
•••
•••
WuXi AppTec (China)
•••
•••
•••
•••
Eurofins Scientific (Luxembourg)
•••
•••
•••
•••
IQVIA (U.S.)
•••
•••
•••
•••
SGS Société Générale de Surveillance SA (Switzerland)
•••
•••
•••
•••
Intertek Group plc (U.K.)
•••
•••
•••
•••
Syneos Health. (U.K.)
•••
•••
•••
•••
ICON plc (Ireland)
•••
•••
•••
•••
PPD Inc. (U.S.)
•••
•••
•••
•••
Parexel International Corporation. (U.S.)
•••
•••
•••
•••
Almac Group (U.K.)
•••
•••
•••
•••
Altasciences. (Canada)
•••
•••
•••
•••
BioAgilytix Labs. (U.S.)
•••
•••
•••
•••
LGC Limited (U.K.)
•••
•••
•••
•••
Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.
According to Cognitive Market Research, the global DNA Testing Service Market size was USD 19254.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 9.00% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 7701.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.4% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 5776.35 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 4428.54 million in 2024 and will grow at a compound annual growth rate (CAGR) of 15.2% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 962.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.6% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 385.09 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.9% from 2024 to 2031.
The animal tissue category is the fastest growing segment of the DNA Testing Service industry
Introduction of the DNA Testing Service Market
Drugs and their metabolites are detected in biological metrics using bioanalytical testing equipment. Fluids, main blood, plasma, tissue extracts, serum, or urine are a few examples. It can also be used as an analytical technique to examine biological products. The processes of a bioanalytical program comprise sample preparation, creation of bioanalytical techniques, validation, and guaranteeing quantitative results with stability, accuracy, selectivity, and precision. Cleaning the test sample before to analysis and condensing it for improved detection are examples of sample preparation. Drug concentrations, metabolites, and pharmacodynamic indicators in bodily fluids are measured using bioanalytical testing services. These services provide reliable sample analysis results as well as method validation to guarantee results that exhibit precision, accuracy, selectivity, and stability. Utilizing resources as efficiently as possible is driving up the popularity of outsourcing bioanalytical services. Modern equipment notwithstanding, specialized in-house laboratories might not be equipped to perform intricate bioanalytical testing.
In September 2023, CIRION BioPharma Research, a Canadian contract research laboratory, was acquired by Cerba HealthCare in order to improve bioanalytical skills and expedite the implementation of difficult clinical studies. (Source: https://cerbaresearch.com/news/cerba-healthcare-to-acquire-canadian-contract-research-laboratory-cirion-biopharma-research/)
Global DNA Testing Services Market Analysis Insights Video
Analyst Conclusion
Conclusion
The global DNA Testing Service Market will expand significantly by 13.20% CAGR between 2024 and 2031.
Animal tissues are expected to dominate the DNA Testing Service Market over the forecast period. Animal productivity, health, and conservation efforts are all enhanced by DNA testing.
The PCR Based segment has the biggest market share. PCR testing, in contrast to many other tests, can identify illness even in the early stages of infection
Supriya Yadav
Research Analyst · Cognitive Market Research
Supriya is a Team Lead at Cognitive Market Research & Consulting, leading research initiatives and strategic intelligence projects across the Healthcare, Pharmaceuticals, and Medical Devices & Consumables sectors. With more than two years of experience in market research and data analysis, she plays a key role in helping organizations navigate complex healthcare ecosystems, identify emerging opportunities, and make informed business decisions through data-driven insights and market intelligence.
Combining expertise in both primary and secondary research methodologies with a strong academic foundation in Marketing and Finance, Supriya oversees the execution of market assessments, competitive intelligence studies, forecasting models, stakeholder interviews, trend analysis, and custom consulting engagements. She collaborates with healthcare providers, pharmaceutical manufacturers, medical device companies, industry experts, and other key stakeholders to gather firsthand market perspectives while validating findings through extensive research. Her ability to interpret clinical, commercial, and market data enables clients to better understand industry developments, regulatory influences, innovation trends, and competitive dynamics.
In her leadership role, she manages end-to-end research projects and guides cross-functional teams in delivering high-quality market reports, consulting solutions, and strategic studies. Her expertise in market estimation, forecasting, and analytical modeling helps organizations evaluate market potential, assess growth opportunities, strengthen competitive positioning, and support strategic planning initiatives. By transforming complex healthcare and life sciences data into actionable business intelligence, she enables clients to make confident decisions in rapidly evolving market environments.
Driven by a passion for healthcare innovation and continuous professional development, Supriya remains committed to staying ahead of industry trends, technological advancements, and changing market conditions. Her leadership, analytical mindset, and dedication to research excellence help organizations mitigate risks, capitalize on emerging opportunities, and achieve sustainable growth across the global healthcare and life sciences landscape.
The global market size for DNA Testing Service in 2024 is USD 19254.5 million.
The global DNA Testing Service Market is expected to grow with a CAGR of 13.20% over the projected period.
North America held a significant global DNA Testing Service Market revenue share in 2024.
Asia-Pacific will witness the fastest growth of the global DNA Testing Service Market over the coming years.
The US had the most significant global DNA Testing Service Market revenue share in 2024.
The main driver of the growth of the DNA Testing Service Market is the Growing Uses (predictive testing, forensic science, and prenatal testing) and Technological developments (AI, next-generation sequencing, etc.).
The pharmaceuticals category dominates the market.
★ Reviews
Rate this report
Global DNA Testing Services Market Analysis — Table of Contents
Disclaimer: Redacted sample for representative purposes. Charts and data do not depict actual statistics. TOC varies by license selection.
License Edition
Country
Plant
Trace Cells, Paraffin Tissue, Others d
Application
Hospital, Clinic, Laboratory, Others
Technique
PCR, Sanger Sequencing, Next-Generation Sequencing, In-Situ Hybridization, RFLP, SNP Genotyping
End-user
Pharmaceuticals, Forensics, Research Institutes, Biotechnology, Consumer Genomics, Agrigenomics
List of Competitors
Charles River Laboratories (U.S.), Medpace (U.S.), WuXi AppTec (China), Eurofins Scientific (Luxembourg), IQVIA (U.S.), SGS Société Générale de Surveillance SA (Switzerland), Intertek Group plc (U.K.), Syneos Health. (U.K.), ICON plc (Ireland), PPD Inc. (U.S.), Parexel International Corporation. (U.S.), Almac Group (U.K.), Altasciences. (Canada), BioAgilytix Labs. (U.S.), LGC Limited (U.K.)
1.1 Global Power Realignment & Strategic Alliances
18.6 Future Gross Margin Outlook and Profitability Trends
19.1 Key Takeaways
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study.
You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
19.2 Analyst Point of View
19.3 Assumptions and Acronyms
20.1 Primary Data Collection
20.1.1 Steps for Primary Data Collection
20.1.1.1 Identification of KOL
20.1.2 Backward Integration
20.1.3 Forward Integration
20.1.4 How Primary Research Help Us
20.1.5 Modes of Primary Research
20.2 Secondary Research
20.2.1 How Secondary Research Help Us
20.2.2 Sources of Secondary Research
20.3 Data Validation
20.3.1 Data Triangulation
20.3.2 Top Down & Bottom Up Approach
20.3.3 Cross check KOL Responses with Secondary Data
20.4 Data Representation
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Global DNA Testing Services Market Analysis Market analysis.
01
Primary Intelligence Gathering
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
02
Secondary Data Triangulation
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
03
Expert Validation Protocol
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
04
Athenaeum AI Processing
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
05
Editorial & QA Review
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Global DNA Testing Services Market Analysis market.
Service 01
Market Survey
B2BB2C
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the global dna testing services market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
What's Included
Buyer intent & sentiment analysis
Purchase cycle mapping
Price sensitivity research
Channel preference profiling
Competitive perception study
Most Requested
Service 02
Customized Market Data & Reports
CustomReady Report
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
What's Included
Ready syndicate report (250+ pages)
Custom data scope & segmentation
Excel quantitative models
Board-ready PPT with key findings
Secure cloud portal access
Service 03
Strategic Consultation
With SurveyWith Report
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
What's Included
Dedicated analyst assigned to you
Live walkthrough of findings
Strategic Q&A sessions
Go-to-market recommendations
NDA-protected engagement
Customize This Report
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.
